Willingness to pay for a mosquito bite prevention 'forest pack' in Cambodia: results of a discrete choice experiment.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2002-
    • Subject Terms:
    • Abstract:
      Background: Progress towards malaria elimination in the Greater Mekong Subregion has left much of the residual malaria transmission concentrated among forest-exposed populations for whom traditional domicile focused malaria vector control is unlikely to be effective. New tools to protect these populations from vector biting outdoors are needed.
      Methods: Alongside implementation research on the deployment of a "forest pack" consisting of a volatile pyrethroid (transfluthrin)-based spatial repellent (VPSR), a picaridin-based topical repellent and etofenprox treatment of clothing, an assessment was made of participant willingness to pay for the forest packs and variants of the packs using a discrete choice experiment.
      Results: Participants showed willingness to pay for forest packs consistent with full-cost recovery for VPSR devices. The inclusion of a full malaria season's worth of VPSR devices increased the willingness to pay for a forest pack by 15% (p = 0.061). At a price of approximately 10 USD, approximately 50% of participants were willing to pay for a forest pack which included a full season's worth of VPSR.
      Conclusion: Forest packs which include VPSR are likely to be acceptable to the target forest-exposed populations, and those which include VPSR products may even have potential for commercial sales or some cost-recovery.
      Competing Interests: Declarations. Ethics approval and consent to participate: The study protocol was approved by the University of California’s Human Research Protection Program Institutional Review Board (IRB 22-36956) and the Cambodia Ministry of Health National Ethics Committee for Health Research (NECHR 296). Informed consent was sought by each participant prior to enrollment. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
      (© 2024. The Author(s).)
    • References:
      Malar J. 2019 Feb 1;18(1):32. (PMID: 30709399)
      Malar J. 2015 Apr 24;14:165. (PMID: 25908498)
      J Environ Manage. 2016 Dec 1;183:98-109. (PMID: 27576151)
      PLoS One. 2009 Oct 07;4(10):e7369. (PMID: 19809502)
      BMC Infect Dis. 2022 Sep 24;22(1):747. (PMID: 36153501)
      PLoS One. 2022 Sep 9;17(9):e0274320. (PMID: 36083983)
      PLoS One. 2012;7(1):e29991. (PMID: 22253852)
      Eur J Health Econ. 2018 Nov;19(8):1053-1066. (PMID: 29380229)
      Med Vet Entomol. 2016 Jun;30(2):229-34. (PMID: 26991881)
      Malar J. 2021 Jan 20;20(1):51. (PMID: 33472630)
      Malar J. 2022 Jul 2;21(1):209. (PMID: 35780142)
      Malar J. 2023 Sep 1;22(1):251. (PMID: 37658337)
      Health Econ. 2011 Mar;20(3):323-30. (PMID: 20217834)
      Sci Rep. 2021 Mar 19;11(1):6458. (PMID: 33742030)
      Malar J. 2010 Dec 23;9:373. (PMID: 21182774)
      BMC Med Res Methodol. 2015 Mar 12;15:19. (PMID: 25887890)
      Health Econ. 2012 Feb;21(2):145-72. (PMID: 22223558)
      Malar J. 2020 Nov 19;19(1):413. (PMID: 33213471)
      Trop Med Int Health. 2005 Mar;10(3):251-62. (PMID: 15730510)
      Malar J. 2010 Feb 23;9:57. (PMID: 20175930)
      Malar J. 2019 Nov 27;18(1):376. (PMID: 31771587)
      Clin Infect Dis. 2018 Aug 31;67(6):817-826. (PMID: 29522113)
      Sci Rep. 2024 Jul 29;14(1):17348. (PMID: 39069597)
      Malar J. 2021 Sep 17;20(1):370. (PMID: 34535133)
      Patient. 2015 Oct;8(5):373-84. (PMID: 25726010)
      PLoS One. 2012;7(5):e37166. (PMID: 22662135)
      PLoS Med. 2019 Feb 15;16(2):e1002745. (PMID: 30768615)
      J Infect Dis. 2021 Apr 27;223(12 Suppl 2):S111-S142. (PMID: 33906222)
      Am J Trop Med Hyg. 2019 May;100(5):1170-1178. (PMID: 30860021)
      Malar J. 2020 Apr 15;19(1):151. (PMID: 32293452)
    • Grant Information:
      A134328 Innovative Vector Control Consortium
    • Contributed Indexing:
      Keywords: Cambodia; Discrete choice; Greater Mekong Subregion; Malaria; Spatial repellent; Topical repellent; Vector control; Willingness to pay
    • Accession Number:
      0 (Insect Repellents)
      0 (Pyrethrins)
      QWL3SKA6EG (transfluthrin)
      0 (Insecticides)
      N51GQX0837 (picaridin)
      0 (Cyclopropanes)
      0 (Fluorobenzenes)
      0 (Piperidines)
    • Publication Date:
      Date Created: 20241220 Date Completed: 20241220 Latest Revision: 20250104
    • Publication Date:
      20250104
    • Accession Number:
      PMC11658235
    • Accession Number:
      10.1186/s12936-024-05224-2
    • Accession Number:
      39702135